We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Siemens Forms Molecular Imaging Unit

By HospiMedica staff writers
Posted on 28 Jun 2005
Siemens Medical Solutions (Erlangen, Germany)has announced that it has formed a new division called Siemens Medical Solutions Molecular Imaging, which combines its nuclear medicine operations with CTI Molecular Imaging, Inc. (Culver City, CA, USA), a leading developer of positron emission tomography (PET) imaging equipment and services.

CTI is a wholly owned subsidiary of Siemens Medical Solutions, acquired by Siemens in May 2005 in a transaction valued at around U.S.$1 billion. With this acquisition and the formation of a division centered on PET and single photon emission computed tomography (SPECT)-based molecular imaging technologies, Siemens strengthens its dedication to molecular imaging development, technologic innovation, and the creation of dynamic new technologies that will update the diagnosis and treatment of disease. This includes the development and distribution of molecular biomarkers, preclinical imaging for research and pharmaceuticals, and application and post-processing for molecular imaging.

"Uniting Siemens Nuclear Medicine with CTI to form a new molecular
imaging division supports our vision to be the innovation trendsetter
in the healthcare industry,” said Erich Reinhardt, Ph.D., president and CEO, Siemens Medical Solutions.

"CTI and Siemens are two pioneering companies in the healthcare technology field,” said Ronald Nutt, Ph.D., founder and former president and CEO of CTI Molecular Imaging, who is now the chief scientific advisor of the new Siemens division. "This new partnership marks an exciting step in our quest to discover and pursue new paths in molecular medicine, and reflects our overall strategy to personalize healthcare and positively impact the way illness is identified and treated.”





Related Links:
Siemens Medical Solutions
CTI Molecular Imaging
Portable X-ray Unit
AJEX140H
Digital X-Ray Detector Panel
Acuity G4
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Diagnostic Ultrasound System
DC-80A

Channels

Nuclear Medicine

view channel
Image: CXCR4-targeted PET imaging reveals hidden inflammatory activity (Diekmann, J. et al., J Nucl Med (2025). DOI: 10.2967/jnumed.125.270807)

PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack

Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.